Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intraoperational Prostate Loge Biopsies (iPROLOGX) After Radical Prostatovesiculectomy (RPVE) in Prostate Cancer (PCA) Patients for Molecular Tumor Marker Analysis

NCT02460861 is registered in ClinicalTrials.gov with University of Magdeburg as lead sponsor.

NCT NCT02460861
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02460861 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intraoperational Prostate Loge Biopsies (iPROLOGX) After Radical Prostatovesiculectomy (RPVE) in Prostate Cancer (PCA) Patients for Molecular Tumor Marker Analysis
Lead sponsor
University of Magdeburg
Phase
Not applicable
Overall status
Unknown status
Start date
November 30, 2011
Completion date
December 31, 2015
Enrollment
279 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer